Drugs / Oxycodone/naloxone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01811238 | Sep 2012 → Apr 2013 | vertebral column disorder | Mundipharma Korea Ltd | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oxycodone/naloxone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01811238 ↗ |
| Route | Oral | “received prolonged-release oral oxycodone/naloxone at a starting dose of 10/5 mg/day” PMID 29564045 ↗ Feb 2018 |